Oppenheimer analyst Leland Gershell downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Outperform to Perform.The analyst commented, "We caught up with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE